文献速递肺外科

复杂肺段切除术的肿瘤学结局:多中心倾向性评分匹配分析

Oncologic Outcomes of Complex Segmentectomy: A Multicenter Propensity Score-Matched Analysis.
PubMed 文献 · Ann Thorac Surg · 2020-08-12

该多中心回顾性研究纳入1517例临床I期、实性成分≤2.0 cm的肺癌患者,比较复杂肺段切除术(240例)与位置调整肺叶切除术(851例)的肿瘤学结局。倾向性评分匹配219对后,两组5年癌症特异性生存率和无复发生存间期均无显著差异,复杂肺段切除术显示出可接受的肿瘤学结局。

要点

  • 复杂肺段切除术与肺叶切除术的5年癌症特异性生存率和无复发生存间期无显著差异
  • 倾向性评分匹配后复杂肺段切除术5年CSS为96.0%,肺叶切除术为97.8%
  • 复杂肺段切除术可用于临床I期、实性成分≤2.0 cm的肺癌治疗

核心结论

  • 复杂肺段切除术在临床I期肺癌治疗中提供可接受的肿瘤学结局。

研究设计与样本

  • 多中心回顾性队列研究,纳入2010至2018年间3家机构1517例临床I期、实性成分≤2.0 cm的肺癌手术患者。
  • 复杂肺段切除术240例,位置调整肺叶切除术851例,并进行倾向性评分匹配分析。

主要发现

  • 纯实性肿瘤亚组分析中同样观察到该趋势。
  • 倾向性评分匹配219对后,复杂肺段切除术5年CSS为96.0%、RFI为95.5%,肺叶切除术分别为97.8%和95.9%。
  • 倾向性评分调整多变量分析显示,复杂肺段切除术与肺叶切除术的RFI风险比无显著差异(HR=0.98,95%CI 0.33-2.40,P=0.98)。

临床怎么用

  • 对于临床I期、实性成分≤2.0 cm的肺癌患者,复杂肺段切除术可作为肺叶切除术的替代选择之一。

局限性

  • 本研究为回顾性分析,存在选择偏倚可能。
  • 复杂肺段切除术组样本量相对较小(240例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Complex segmentectomy creates several intricate intersegmental planes; however, it has not been fully established in lung cancer treatment. We compared the oncologic outcomes of complex segmentectomy and lobectomy through a large cohort, multicenter database using propensity score-matched analysis. METHODS: We retrospectively analyzed data from 1517 patients with clinical stage I lung cancer with a solid component size 2.0 cm or less, who underwent surgical resection at 3 institutions between 2010 and 2018. Complex segmentectomy (n = 240) and location-adjusted lobectomy (n = 851) as well as surgical results were analyzed for all patients and their propensity score-matched pairs. RESULTS: The prognosis of patients undergoing complex segmentectomy was not significantly different from that of patients undergoing lobectomy (5-year cancer-specific survival [CSS] rate, 96.4% versus 97.2%, P = .69; and 5-year recurrence-free interval [RFI] rate, 95.8% versus 93.4%, P = .19). This trend was also identified in subanalyses for pure solid tumors. However, there were major differences in clinicopathologic features between the 2 groups. After propensity score-matched analysis, proper matching of patients was ascertained. In 219 propensity score-matched pairs, long-term outcomes were similar between patients undergoing complex segmentectomy (5-year CSS, 96.0%; 5-year RFI, 95.5%) and lobectomy (5-year CSS, 97.8%; 5-year RFI, 95.9%). Propensity score-adjusted multivariable analysis for RFI revealed that prognosis associated with complex segmentectomy was comparable to the prognosis obtained with lobectomy (hazard ratio = 0.98; 95% confidence interval, 0.33-2.40; P = .98). CONCLUSIONS: Complex segmentectomy provides acceptable oncologic outcomes in clinical stage I lung cancer treatment.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Handa Y, Tsutani Y, Mimae T, et al. Oncologic Outcomes of Complex Segmentectomy: A Multicenter Propensity Score-Matched Analysis. Ann Thorac Surg. 2020. PMID: 32795524. doi:10.1016/j.athoracsur.2020.06.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。